10x Genomics Inc. Class A Common Stock (1KJ)
Munich
Closed
Sep 14, 2026
Day's Range
58.2552 wk Range
9.81Overview - 1KJ - 10x Genomics Inc. Class A Common Stock
Key Statistics
Valuation
Enterprise Value
-389.60M
P/E (Trailing)
‪-166.42‬
PEG Ratio
‪1.10‬
Price / Book
‪9.17‬
EV / EBITDA
‪8.47‬
Profitability
Gross Margin
‪74.48%‬
Profit Margin
‪69.05%‬
Operating Margin
‪-6.20%‬
Return on Assets
‪-4.18%‬
Return on Equity
‪-5.46%‬
Ownership
Shares Outstanding
130.28M
Price stats
50-Day Avg
‪45.38‬
200-Day Avg
‪25.67‬
Peers - 1KJ - 10x Genomics Inc. Class A Common Stock
Peer Comparison
Compared with companies in Health Information Services listed on Munich.
- 1KJMunich10x Genomics Inc.+81.29%52-week change-166.43P/E (Trailing)‪69.05%‬Profit Margin
- 0NI0MunichLogicMark, Inc.+99.87%52-week change-122.29P/E (Trailing)‪-49.64%‬Profit Margin
- P990MunichCodeLab Capital AS+55.24%52-week change-0.47P/E (Trailing)‪-51.83%‬Profit Margin
- UY00MunichTripsitter Clinic Ltd.+45.55%52-week change—P/E (Trailing)—Profit Margin
- SD3MunichSimulations Plus Inc.+35.22%52-week change-4.94P/E (Trailing)‪58.37%‬Profit Margin
- 4KLMunichUBERDOC Health Technologies Corp.+32.63%52-week change—P/E (Trailing)—Profit Margin
- I82MunichCarlsmed Inc.+29.78%52-week change-6.42P/E (Trailing)‪75.31%‬Profit Margin
Profile Summary - 1KJ - 10x Genomics Inc. Class A Common Stock
About
10x Genomics develops and sells instruments, consumables, and software for analyzing biological systems globally. The company specializes in single cell and spatial biology, enabling researchers to study individual cells and understand complex biological processes at unprecedented resolution. Its primary platforms…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
